Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 149316, 7 pages
http://dx.doi.org/10.1155/2014/149316
Research Article

Interpretation of ANA Indirect Immunofluorescence Test Outside the Darkroom Using NOVA View Compared to Manual Microscopy

1ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
2Departments of Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
3INOVA Diagnostics, Inc. San Diego, 9900 Old Grove Road, CA 92131, USA
4ARUP Institute for Clinical and Experimental Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
5Departments of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
6Departments of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA

Received 15 November 2013; Revised 3 January 2014; Accepted 6 January 2014; Published 24 February 2014

Academic Editor: Michael Mahler

Copyright © 2014 Susan S. Copple et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. L. Meroni and P. H. Schur, “ANA screening: an old test with new recommendations,” Annals of the Rheumatic Diseases, vol. 69, no. 8, pp. 1420–1422, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. R. W. Burlingame and C. Peebles, “Detection of antibodies,” in Autoantibodies and Autoimmunity: Molecular Mechanisms in Health and Disease, K. M. Pollard, Ed., pp. 159–188, Wiley-VCH, Weinheim, Germany, 2006. View at Google Scholar
  3. S. S. Copple, S. R. Giles, T. D. Jaskowski, A. E. Gardiner, A. M. Wilson, and H. R. Hill, “Screening for IgG antinuclear autoantibodies by HEp-2 indirect fluorescent antibody assays and the need for standardization,” American Journal of Clinical Pathology, vol. 137, pp. 825–830, 2012. View at Publisher · View at Google Scholar
  4. B. M. Van, C. C. Van, X. Bossuyt et al., “Current practices in antinuclear antibody testing: results from the belgian external quality assessment scheme,” Clinical Chemistry and Laboratory Medicine, vol. 47, no. 1, pp. 102–108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Fritzler, A. Wiik, E. M. Tan et al., “A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. comparative performance characteristics of academic and manufacturers' laboratories,” Journal of Rheumatology, vol. 30, no. 11, pp. 2374–2381, 2003. View at Google Scholar · View at Scopus
  6. L. K. Peterson, D. Wells, L. Shaw, M. G. Velez, R. Harbeck, and L. L. Dragone, “Novel method for quantitative ANA measurement using near-infrared imaging,” Journal of Immunological Methods, vol. 349, no. 1-2, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. U. Sack, K. Conrad, E. Csernok et al., “Autoantibody detection using indirect immunofluorescence on HEp-2 cells,” Annals of the New York Academy of Sciences, vol. 1173, pp. 166–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Egner, “The use of laboratory tests in the diagnosis of SLE,” Journal of Clinical Pathology, vol. 53, no. 6, pp. 424–432, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Fenger, A. Wiik, M. Hoier-Madsen et al., “Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis,” Clinical Chemistry, vol. 50, no. 11, pp. 2141–2147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. R. Bradwell, R. G. Hughes, and A. R. Karim, “Immunofluorescent antinuclear antibody tests,” in Manual of Clinical Laboratory Immunology, B. Detrick, R. G. Hamilton, and J. D. Folds, Eds., pp. 995–1006, ASM press, Washington, DC, USA, 7th edition, 2006. View at Google Scholar
  11. W. Emlen and L. O'neill, “Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays,” Arthritis and Rheumatism, vol. 40, no. 9, pp. 1612–1618, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Tonutti, D. Bassetti, A. Piazza et al., “Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits,” Autoimmunity, vol. 37, no. 2, pp. 171–176, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. E. M. Tan, J. S. Smolen, J. S. Mcdougal et al., “A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precisionsensitivity, and specificity,” Arthritis & Rheumatology, vol. 42, pp. 455–464, 1999. View at Google Scholar
  14. A. J. Swaak, “Diagnostic significance of antinuclear antibodies in clinical practice,” Nederlands Tijdschrift Voor Geneeskunde, vol. 144, no. 13, pp. 585–589, 2000. View at Google Scholar · View at Scopus
  15. X. Qin, X. Tao, Z. J. Chen et al., “Comparison of indirect immunofluorescence assay and ELISA for detecting antinuclear antibodies and anti-double-stranded DNA antibodies,” Nan Fang Yi Ke Da Xue Xue Bao, vol. 29, no. 3, pp. 472–475, 2009. View at Google Scholar · View at Scopus
  16. P. Perner, H. Perner, and B. Müller, “Mining knowledge for Hep-2 cell image classification,” Journal Artificial Intelligence in Medicine, vol. 26, no. 1, pp. 161–173, 2002. View at Publisher · View at Google Scholar
  17. K. Egerer, D. Roggenbuck, R. Hiemann et al., “Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests,” Arthritis Research & Therapy, vol. 12, article R40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Hiemann, T. Buttner, T. Krieger, D. Roggenbuck, U. Sack, and K. Conrad, “Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells,” Autoimmunity Reviews, vol. 9, no. 1, pp. 17–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Willitzki, R. Hiemann, V. Peters et al., “New platform technology for comprehensive serological diagnostics of autoimmune diseases,” Clinical and Developmental Immunology, vol. 2012, Article ID 284740, 8 pages, 2012. View at Publisher · View at Google Scholar
  20. J. Voigt, C. Krause, E. Rohwader et al., “Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells,” Clinical and Developmental Immunology, vol. 2012, Article ID 651058, 7 pages, 2012. View at Publisher · View at Google Scholar
  21. D. Roggenbuck, R. Hiemann, P. Schierack, D. Reinhold, and K. Conrad, “Digital immunofluorescence enables automated detection of antinuclear antibody endpoint titers avoiding serial dilution,” Clinical Chemistry and Laboratory Medicine, vol. 52, no. 2, pp. e9–e11, 2013. View at Publisher · View at Google Scholar
  22. C. Bonroy, C. Verfaillie, V. Smith et al., “Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation,” Clinical Chemistry and Laboratory Medicine, vol. 51, no. 9, pp. 1771–1779, 2013. View at Publisher · View at Google Scholar
  23. X. Bossuyt, S. Cooreman, B. H. De et al., “Detection of antinuclear antibodies by automated indirect immunofluorescence analysis,” Clinica Chimica Acta, vol. 415, pp. 101–106, 2013. View at Publisher · View at Google Scholar
  24. P. Foggia, G. Percannella, P. Soda, and M. Vento, “Benchmarking HEp-2 cells classification methods,” IEEE Transactions on Medical Imaging, vol. 32, no. 10, pp. 1878–1889, 2013. View at Publisher · View at Google Scholar
  25. D. Roggenbuck, R. Hiemann, D. Bogdanos, D. Reinhold, and K. Conrad, “Standardization of automated interpretation of immunofluorescence tests,” Clinica Chimica Acta, vol. 421, pp. 168–169, 2013. View at Publisher · View at Google Scholar
  26. M. Mahler, M. J. Fritzler, and M. Bluthner, “Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies,” Arthritis research & Therapy, vol. 7, no. 1, pp. R19–R29, 2005. View at Google Scholar · View at Scopus
  27. N. Bizzaro, A. Antico, S. Platzgummer et al., “Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems,” Autoimmunity Reviews, vol. 13, no. 3, pp. 292–298, 2013. View at Publisher · View at Google Scholar
  28. N. Agmon-Levin, J. Damoiseaux, C. Kallenberg et al., “International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies,” Annals of the Rheumatic Diseases, 2013. View at Publisher · View at Google Scholar
  29. S. Schouwers, M. Bonnet, P. Verschueren et al., “Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysis,” Clinical Chemistry and Laboratory Medicine, vol. 13, pp. 1–5, 2013. View at Publisher · View at Google Scholar